Select Medical
SEM was delisted on the 30th of June, 2026.
204 hedge funds and large institutions have $1.51B invested in Select Medical in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 73 increasing their positions, 77 reducing their positions, and 39 closing their positions.
0.66% less ownership
Funds ownership: 77.01% → 76.35% (-0.66%)
3% less capital invested
Capital invested by funds: $1.55B → $1.51B (-$41.3M)
5% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 77
6% less funds holding
Funds holding: 218 → 204 (-14)
20% less call options, than puts
Call options by funds: $567K | Put options by funds: $711K
33% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 39
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.2M |
| 3 |
HAM
Hillcrest Asset Management
Plano,
Texas
|
+$10.3M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5.99M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$13M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$12.2M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$9.5M |
| 4 |
Morgan Stanley
New York
|
-$8.68M |
| 5 |
PCM
PAR Capital Management
Boston,
Massachusetts
|
-$8.52M |
SEM Hedge Fund Activity: Q2 2020 in Review
204 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2020, worth a combined $1.51B — down 2.7% from $1.55B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of SEM and 26 opened new positions — a net loss of 13 holders — while 77 trimmed existing stakes and 73 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $27.7M. The largest seller was Renaissance Technologies, cutting an estimated $13M.
- 204 institutional investors held Select Medical (SEM) as of Q2 2020, down from 218 in Q1 2020.
- Funds reported $1.51B of Select Medical stock for Q2 2020, down 2.7% quarter-over-quarter.
- 26 funds opened new Select Medical positions in Q2 2020 and 39 closed out, a net change of -13 holders.
- The largest Select Medical buyer in Q2 2020 was T. Rowe Price Associates, an estimated $27.7M added.
- The largest Select Medical seller in Q2 2020 was Renaissance Technologies, an estimated $13M sold.
Based on aggregated 13F filings for Q2 2020.